Friedreich Ataxia
Symptoms, Doctors, Treatments, Advances & More

Learn About Friedreich Ataxia

View Main Condition: Movement Disorders

What is the definition of Friedreich Ataxia?

Friedreich ataxia is a rare disease passed down through families (inherited). It affects the muscles and heart.

What are the alternative names for Friedreich Ataxia?

Friedreich's ataxia; Spinocerebellar degeneration

What are the causes of Friedreich Ataxia?

Friedreich ataxia is caused by a defect in a gene called frataxin (FXN). Changes in this gene cause the body to make too much of a part of DNA called trinucleotide repeat (GAA). Normally, the body contains about 8 to 30 copies of GAA. People with Friedreich ataxia have as many as 1,000 copies. The more copies of GAA a person has, the earlier in life the disease starts and the faster it gets worse.

Friedreich ataxia is an autosomal recessive genetic disorder. This means you must get a copy of the defective gene from both your mother and father.

What are the symptoms of Friedreich Ataxia?

Symptoms are caused by the wearing away of structures in areas of the brain and spinal cord that control coordination, muscle movement, and other functions. Symptoms most often begin before puberty. Symptoms may include:

  • Abnormal speech
  • Changes in vision, particularly color vision
  • Decrease in ability to feel vibrations in lower limbs
  • Foot problems, such as hammer toe and high arches
  • Hearing loss, this occurs in about 10% of people
  • Jerky eye movements
  • Loss of coordination and balance, which leads to frequent falls
  • Muscle weakness
  • No reflexes in the legs
  • Unsteady gait and uncoordinated movements (ataxia), which gets worse with time

Muscle problems lead to changes in the spine. This may result in scoliosis or kyphoscoliosis.

Heart disease commonly develops and may lead to heart failure. Heart failure or dysrhythmias that do not respond to treatment may result in death. Diabetes may develop in later stages of the disease.

Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Friedreich Ataxia?

Treatment for Friedreich ataxia includes:

  • Counseling
  • Speech therapy
  • Physical therapy
  • Walking aids or wheelchairs

A new medicine, omaveloxolone (Skyclarys), was approved by FDA in 2023 to slow disease progression. Orthopedic devices (braces) may be needed for scoliosis and foot problems. Treating heart disease and diabetes help people live longer and improve their quality of life.

Who are the top Friedreich Ataxia Local Doctors?
Elite in Friedreich Ataxia
Elite in Friedreich Ataxia
50 Flemington Road, 
Parkville, VIC, AU 

Martin Delatycki practices in Parkville, Australia. Mr. Delatycki is rated as an Elite expert by MediFind in the treatment of Friedreich Ataxia. His top areas of expertise are Friedreich Ataxia, Spinocerebellar Ataxia, Drug Induced Dyskinesia, and Hereditary Ataxia.

Elite in Friedreich Ataxia
Elite in Friedreich Ataxia
Brussels, BRU, BE 

Massimo Pandolfo practices in Brussels, Belgium. Mr. Pandolfo is rated as an Elite expert by MediFind in the treatment of Friedreich Ataxia. His top areas of expertise are Friedreich Ataxia, Spinocerebellar Ataxia, Drug Induced Dyskinesia, and Hereditary Ataxia.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Friedreich Ataxia
Elite in Friedreich Ataxia
Flemington Road, 
Parkville, VIC, AU 

Louise Corben practices in Parkville, Australia. Ms. Corben is rated as an Elite expert by MediFind in the treatment of Friedreich Ataxia. Her top areas of expertise are Friedreich Ataxia, Spinocerebellar Ataxia, Drug Induced Dyskinesia, and Hereditary Ataxia.

What is the outlook (prognosis) for Friedreich Ataxia?

Friedreich ataxia slowly gets worse and causes problems doing everyday activities. Most people need to use a wheelchair within 15 years of the disease's start. The disease may lead to early death.

What are the possible complications of Friedreich Ataxia?

Complications may include:

  • Diabetes
  • Heart failure or heart disease
  • Loss of ability to move around
When should I contact a medical professional for Friedreich Ataxia?

Contact your health care provider if symptoms of Friedreich ataxia occur, especially if there is a family history of the disorder.

How do I prevent Friedreich Ataxia?

People with a family history of Friedreich ataxia who intend to have children may want to consider genetic screening to determine their risk.

What are the latest Friedreich Ataxia Clinical Trials?
Characteristics And Clinical Course Of Disease In Participants With Cardiomyopathy Associated With Friedreich Ataxia (CLARITY-FA)

Summary: Characteristics and clinical course of disease In participants with cardiomyopathy associated with Friedreich Ataxia (CLARITY-FA)

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 3, 2-Part, Randomized, Double-Blind, Placebo-Controlled Study (Part 1) and Open-Label Extension (Part 2) to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Omaveloxolone (BIIB141) in Participants With Friedreich's Ataxia Aged 2 to < 16 Years

Summary: In this study, researchers will learn more about the effects and safety of BIIB141, also known as omaveloxolone or SKYCLARYS®. This drug has been approved, or made available for doctors to prescribe, for people with Friedreich's Ataxia (FA) who are at least 16 years old. But, it is not yet available for children and teens with FA who are younger than 16 years old. The main objective of this study ...

Who are the sources who wrote this article ?

Published Date: November 06, 2024
Published By: Anna C. Edens Hurst, MD, MS, Associate Professor in Medical Genetics, The University of Alabama at Birmingham, Birmingham, AL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Mink JW. Movement disorders. In: Kliegman RM, St. Geme JW, Blum NJ, et al, eds. Nelson Textbook of Pediatrics. 22nd ed. Philadelphia, PA: Elsevier; 2025:chap 637.

Okun MS, Ostrem JL. Other movement disorders. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 379.